TOL101 is a humanized antibody with alphabeta TCR specificity and acts as a non-depleting T-cell immunomodulator. TOL101 blocks T-cell activation signals by reversibly downregulating the CD3 complex on the surface of alphabeta T cells. TOL101 can be used to study organ transplant rejection and autoimmune diseases.
Purity:
>95.0%
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
